ClearSign Technologies Corporation — Q2 2023 Form 10-Q
Business context and period. This unaudited report covers the three and six months ended June 30, 2023. ClearSign develops combustion and fuel-safety technologies, including low-emissions burner products. Commercial activity remains early-stage, with nominal operating revenue to date. The company reincorporated from Washington to Delaware in June 2023.
Financial results and liquidity
| Metric | Q2 2023 | Six months 2023 | Comparable 2022 period |
|---|---|---|---|
| Revenue | $150,000 | $1.044 million | $0 |
| Cost of goods sold | $21,000 | $809,000 | $0 |
| Gross profit / margin | $129,000 / 86% | $235,000 / 22.5% | $0 |
| Operating expenses | $1.758 million | $3.568 million | $1.660 million / $3.177 million |
| Operating loss | $1.629 million | $3.333 million | $1.660 million / $3.177 million |
| Net loss | $1.478 million | $2.907 million | $1.638 million / $3.128 million |
| Net loss per share | $0.04 | $0.08 | $0.05 / $0.09 |
- Q2 revenue came primarily from an engineering feasibility study and spare-parts sale. First-half revenue primarily reflected process-burner activity, including completion of a customer witness test. Management said the feasibility study’s profit profile was unusually high due to expedited timing and the mix of engineering work.
- Cash and cash equivalents were $7.600 million at June 30, 2023; short-term held-to-maturity investments were $931,000. Working capital was $6.107 million, down from $8.586 million at December 31, 2022.
- Operating cash outflow was $508,000 for the first half, compared with $3.347 million in 2022. The 2023 outflow was aided by a $1.858 million increase in contract liabilities, representing customer payments ahead of future project work. Investing activities provided $1.684 million, largely from net Treasury redemptions; financing activities used $15,000. No common stock was issued through the ATM program in the first half.
- The company reported no contractual debt obligations. Lease liabilities totaled $294,000. Total liabilities were $3.240 million, including $2.105 million of current contract liabilities.
Changes and notable items
- Revenue and gross profit were recorded in 2023, versus none in the comparable 2022 periods. Net loss decreased 9.8% in Q2 and 7.1% for the first half, despite higher operating expenses; gross profit and other income contributed to the improvement.
- First-half general and administrative expense increased 11.8% to $3.221 million. It included a one-time $187,000 RSU vesting charge triggered by a director’s departure and $168,000 of Seattle office decommissioning project-management and refurbishment costs. Q2 included $105,000 of the Seattle-related costs.
- Other income was $151,000 in Q2 and $426,000 in the first half, including interest income, government assistance, and proceeds from selling materials during the Seattle office decommissioning.
- Contract liabilities rose from $247,000 at year-end 2022 to $2.105 million at June 30, 2023. Of the year-end balance, $120,000 was recognized as revenue in the first half.
Outlook, risks and contingencies
- Management stated that cash and short-term investments were sufficient to fund current operating expenses for more than 12 months. The company expects operating losses and negative cash flows for the foreseeable future and depends on commercialization and additional funding over time.
- There is no committed source of financing. Management may pursue equity or debt financing, co-development or strategic-partner arrangements, or licensing or sale of intellectual property. ATM and shelf financing are subject to market conditions and SEC “baby shelf” limits.
- Key risks include customer acceptance and successful commercialization, ongoing funding needs, competition and technology development, manufacturing capability, intellectual-property protection, and operating in China. The company reported nominal revenue to date and no China revenue in either first-half period.
- No formal financial guidance was provided. The company reported no material pending legal proceedings and no material changes to previously disclosed risk factors. Management concluded disclosure controls were effective as of June 30, 2023.
- Subsequent events included a July 31 grant of 150,000 inducement stock options to a new business-development director and an August 8 promotion of Brent Hinds to CFO with specified severance provisions.
Investor verification priorities
- Determine whether the elevated contract-liability balance converts into recognized revenue and cash collections, and review the timing and costs of the associated customer work.
- Assess the repeatability of revenue and gross margins, particularly given management’s characterization of the feasibility-study profit profile as unusually high.
- Track cash burn excluding customer advances, operating-expense trends, and management’s stated runway relative to future financing requirements.
- Review financing capacity and potential dilution, including ATM availability, baby-shelf constraints, outstanding equity awards, and the 150,000 inducement options.
- Monitor commercialization milestones, customer installations, market acceptance, and execution of the company’s strategic partnerships or other funding plans.